Annual Total Debt:
$1.75B+$941.10M(+116.42%)Summary
- As of today (April 25, 2025), VRTX annual total debt is $1.75 billion, with the most recent change of +$941.10 million (+116.42%) on December 31, 2024.
- During the last 3 years, VRTX annual total debt has risen by +$782.10 million (+80.85%).
- VRTX annual total debt is now at all-time high.
Performance
VRTX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$1.75B+$46.60M(+2.74%)Summary
- As of today (April 25, 2025), VRTX quarterly total debt is $1.75 billion, with the most recent change of +$46.60 million (+2.74%) on December 31, 2024.
- Over the past year, VRTX quarterly total debt has increased by +$941.10 million (+116.42%).
- VRTX quarterly total debt is now at all-time high.
Performance
VRTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
VRTX Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.4% | +116.4% |
| 3 y3 years | +80.8% | +112.2% |
| 5 y5 years | +164.4% | +112.2% |
VRTX Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.4% | at high | +142.6% |
| 5 y | 5-year | at high | +164.4% | at high | +235.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.75B(+116.4%) | $1.75B(+2.7%) |
| Sep 2024 | - | $1.70B(+82.4%) |
| Jun 2024 | - | $933.40M(+29.4%) |
| Mar 2024 | - | $721.30M(-10.8%) |
| Dec 2023 | $808.40M(-10.1%) | $808.40M(+8.6%) |
| Sep 2023 | - | $744.70M(-3.0%) |
| Jun 2023 | - | $767.60M(-2.7%) |
| Mar 2023 | - | $789.20M(-12.3%) |
| Dec 2022 | $899.70M(-7.0%) | $899.70M(+9.1%) |
| Sep 2022 | - | $824.60M(-2.7%) |
| Jun 2022 | - | $847.30M(-2.9%) |
| Mar 2022 | - | $872.50M(-9.8%) |
| Dec 2021 | $967.40M(+3.8%) | $967.40M(+10.3%) |
| Sep 2021 | - | $876.80M(-1.9%) |
| Jun 2021 | - | $893.85M(-0.6%) |
| Mar 2021 | - | $898.80M(-3.6%) |
| Dec 2020 | $931.90M(+40.8%) | $931.90M(+70.5%) |
| Sep 2020 | - | $546.51M(+4.7%) |
| Jun 2020 | - | $522.07M(-2.0%) |
| Mar 2020 | - | $532.95M(-19.5%) |
| Dec 2019 | $661.66M(+12.8%) | $661.66M(+9.4%) |
| Sep 2019 | - | $604.54M(-1.2%) |
| Jun 2019 | - | $611.96M(-1.9%) |
| Mar 2019 | - | $623.87M(+6.3%) |
| Dec 2018 | $586.82M(-3.2%) | $586.82M(-0.2%) |
| Sep 2018 | - | $588.04M(-0.8%) |
| Jun 2018 | - | $592.74M(-0.4%) |
| Mar 2018 | - | $595.13M(-1.9%) |
| Dec 2017 | $606.43M(-27.9%) | $606.43M(+3.3%) |
| Sep 2017 | - | $587.19M(+3.3%) |
| Jun 2017 | - | $568.54M(+3.7%) |
| Mar 2017 | - | $548.40M(-34.8%) |
| Dec 2016 | $840.76M(+1.8%) | $840.76M(+2.5%) |
| Sep 2016 | - | $820.32M(-0.0%) |
| Jun 2016 | - | $820.63M(-0.5%) |
| Mar 2016 | - | $824.49M(-0.2%) |
| Dec 2015 | $826.24M(+0.2%) | $826.24M(+0.6%) |
| Sep 2015 | - | $820.98M(-0.4%) |
| Jun 2015 | - | $824.47M(-1.1%) |
| Mar 2015 | - | $833.91M(+1.1%) |
| Dec 2014 | $824.95M(+62.8%) | $824.95M(-0.4%) |
| Sep 2014 | - | $828.24M(+53.9%) |
| Jun 2014 | - | $538.03M(-0.6%) |
| Mar 2014 | - | $541.18M(+6.8%) |
| Dec 2013 | $506.58M(-27.3%) | $506.58M(+13.5%) |
| Sep 2013 | - | $446.38M(+12.2%) |
| Jun 2013 | - | $397.85M(-46.2%) |
| Mar 2013 | - | $739.88M(+6.2%) |
| Dec 2012 | $696.91M(+52.8%) | $696.91M(+74.2%) |
| Sep 2012 | - | $400.00M(0.0%) |
| Jun 2012 | - | $400.00M(0.0%) |
| Mar 2012 | - | $400.00M(-12.3%) |
| Dec 2011 | $455.95M(-15.1%) | $455.95M(-8.5%) |
| Sep 2011 | - | $498.42M(+0.8%) |
| Jun 2011 | - | $494.66M(+0.5%) |
| Mar 2011 | - | $492.10M(-8.4%) |
| Dec 2010 | $536.99M(+249.1%) | $536.99M(+10.2%) |
| Sep 2010 | - | $487.23M(+463.9%) |
| Jun 2010 | - | $86.41M(-31.0%) |
| Mar 2010 | - | $125.32M(-18.5%) |
| Dec 2009 | $153.84M(-46.5%) | $153.84M(-41.5%) |
| Sep 2009 | - | $262.84M(+82.5%) |
| Jun 2009 | - | $144.00M(-49.9%) |
| Mar 2009 | - | $287.50M(0.0%) |
| Dec 2008 | $287.50M(+1337.7%) | $287.50M(0.0%) |
| Sep 2008 | - | $287.50M(0.0%) |
| Jun 2008 | - | $287.50M(0.0%) |
| Mar 2008 | - | $287.50M(+1337.7%) |
| Dec 2007 | $20.00M | $20.00M(0.0%) |
| Sep 2007 | - | $20.00M(-67.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $62.10M(-4.8%) |
| Mar 2007 | - | $65.23M(-47.3%) |
| Dec 2006 | $123.75M(-31.3%) | $123.75M(+21.6%) |
| Sep 2006 | - | $101.75M(-43.5%) |
| Jun 2006 | - | $180.09M(-0.0%) |
| Mar 2006 | - | $180.10M(0.0%) |
| Dec 2005 | $180.10M(-46.2%) | $180.10M(-38.9%) |
| Sep 2005 | - | $294.55M(-12.1%) |
| Jun 2005 | - | $335.00M(0.0%) |
| Mar 2005 | - | $335.00M(0.0%) |
| Dec 2004 | $335.00M(+0.5%) | $335.00M(+4.8%) |
| Sep 2004 | - | $319.69M(-0.9%) |
| Jun 2004 | - | $322.61M(+2.4%) |
| Mar 2004 | - | $315.04M(-5.5%) |
| Dec 2003 | $333.46M(+1.6%) | $333.46M(-3.4%) |
| Sep 2003 | - | $345.33M(+1.3%) |
| Jun 2003 | - | $340.78M(+3.3%) |
| Mar 2003 | - | $329.90M(+0.5%) |
| Dec 2002 | $328.14M(+0.2%) | $328.14M(+1.2%) |
| Sep 2002 | - | $324.28M(-0.3%) |
| Jun 2002 | - | $325.25M(-0.3%) |
| Mar 2002 | - | $326.26M(-0.4%) |
| Dec 2001 | $327.61M(-9.6%) | $327.61M(-8.7%) |
| Sep 2001 | - | $358.75M(+2.9%) |
| Jun 2001 | - | $348.65M(-0.1%) |
| Mar 2001 | - | $349.15M(-3.6%) |
| Dec 2000 | $362.34M(+5033.0%) | $362.34M(-29.2%) |
| Sep 2000 | - | $511.92M(+183.1%) |
| Jun 2000 | - | $180.82M(-0.3%) |
| Mar 2000 | - | $181.43M(+2470.2%) |
| Dec 1999 | $7.06M(-28.0%) | $7.06M(-9.5%) |
| Sep 1999 | - | $7.80M(-7.1%) |
| Jun 1999 | - | $8.40M(-7.7%) |
| Mar 1999 | - | $9.10M(-7.1%) |
| Dec 1998 | $9.80M(+16.7%) | $9.80M(-5.8%) |
| Sep 1998 | - | $10.40M(+8.3%) |
| Jun 1998 | - | $9.60M(+10.3%) |
| Mar 1998 | - | $8.70M(+3.6%) |
| Dec 1997 | $8.40M(-1.2%) | $8.40M(+2.4%) |
| Sep 1997 | - | $8.20M(0.0%) |
| Jun 1997 | - | $8.20M(+1.2%) |
| Mar 1997 | - | $8.10M(-4.7%) |
| Dec 1996 | $8.50M(+21.4%) | $8.50M(+23.2%) |
| Sep 1996 | - | $6.90M(0.0%) |
| Jun 1996 | - | $6.90M(+6.2%) |
| Mar 1996 | - | $6.50M(-7.1%) |
| Dec 1995 | $7.00M(+9.4%) | $7.00M(+2.9%) |
| Sep 1995 | - | $6.80M(-1.4%) |
| Jun 1995 | - | $6.90M(+4.5%) |
| Mar 1995 | - | $6.60M(+3.1%) |
| Dec 1994 | $6.40M(+6.7%) | $6.40M(+1.6%) |
| Sep 1994 | - | $6.30M(+5.0%) |
| Jun 1994 | - | $6.00M(+9.1%) |
| Mar 1994 | - | $5.50M(-8.3%) |
| Dec 1993 | $6.00M(+17.6%) | $6.00M(+1.7%) |
| Sep 1993 | - | $5.90M(0.0%) |
| Jun 1993 | - | $5.90M(+11.3%) |
| Mar 1993 | - | $5.30M(+3.9%) |
| Dec 1992 | $5.10M(+54.5%) | $5.10M(+2.0%) |
| Sep 1992 | - | $5.00M(+13.6%) |
| Jun 1992 | - | $4.40M(+22.2%) |
| Mar 1992 | - | $3.60M(+9.1%) |
| Dec 1991 | $3.30M(+3.1%) | $3.30M(-5.7%) |
| Sep 1991 | - | $3.50M(0.0%) |
| Jun 1991 | - | $3.50M(>+9900.0%) |
| Mar 1991 | - | $0.00(-100.0%) |
| Dec 1990 | $3.20M | $3.20M(>+9900.0%) |
| Sep 1990 | - | $0.00(0.0%) |
| Jun 1990 | - | $0.00(0.0%) |
| Mar 1990 | - | $0.00 |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total debt?
- What is the all time high annual total debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual total debt year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total debt?
- What is the all time high quarterly total debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly total debt year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total debt?
The current annual total debt of VRTX is $1.75B
What is the all time high annual total debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total debt is $1.75B
What is Vertex Pharmaceuticals Incorporated annual total debt year-on-year change?
Over the past year, VRTX annual total debt has changed by +$941.10M (+116.42%)
What is Vertex Pharmaceuticals Incorporated quarterly total debt?
The current quarterly total debt of VRTX is $1.75B
What is the all time high quarterly total debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total debt is $1.75B
What is Vertex Pharmaceuticals Incorporated quarterly total debt year-on-year change?
Over the past year, VRTX quarterly total debt has changed by +$941.10M (+116.42%)